Research suggests need for long-term follow-up for patients with Kawasaki Disease

9 Sep 2015, 4:57 p.m.

Image of Paul Brogan

Kawasaki disease is a rare condition that causes blood vessels to become inflamed and swollen. It predominantly occurs in children under the age of five. If left untreated, it results in balloon-like swellings (aneurysms) in the coronary vessels of approximately 25% of cases. To date, the cause of this disease remains unknown. A group of researchers led by Dr Paul Brogan recently conducted a study aiming to shed light on how the disease develops. Ninety-two children with KD were examined at the Somers Clinical Research Facility (CRF) at GOSH. Levels of circulating endothelial cells (CECs), which are mature cells that have become detached from the vessel wall and are often associated with vascular injury, were measured years after patients developed KD.

The researchers found CECs were elevated in KD patients, usually highest in patients with coronary artery aneurysms. Elevated levels of CECs were also seen in some KD patients that had not had coronary artery aneurysms. While the relevance of elevated CECs are not yet known, this study provides rationale for long-term follow up of these patients.

This study has been accepted for publication in the journal, Heart. It was conducted at the BRC-supported Somers CRF at GOSH. Dr Brogan is a BRC-supported researcher.

New treatment for brain tumour approved after over 20 years of research

The first-ever targeted treatment for brain tumours in children has been approved for NHS patients, following decades of research by a Great Ormond Street consultant.

Help pioneer new treatments for millions of people this DNA Day

DNA Day is coming up this Thursday (25 April) and the team behind the DNA, Children + Young People’s Health Resource (D-CYPHR) are encouraging children and young people to contribute to important health research.

New study finds that nasal cells protect against Covid-19 in children

New research shows that children are less likely than adults to develop severe COVID because cells in their nose are better at fighting off the virus.

New plan announced to get more children access to gene therapy treatments

Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.